BMO MSCI Emerging Markets Income Leaders UCITS ETF

Similar documents
BMO MSCI UK Income Leaders UCITS ETF

Franklin LibertyQ Emerging Markets UCITS ETF

Franklin LibertyQ Global Dividend UCITS ETF

JPMorgan Funds (Ireland) ICAV - Developed World Equity Index Fund

Global Emerging Markets Research Enhanced Index Equity (ESG) UCITS ETF

Xtrackers MSCI Emerging Markets Small Cap UCITS ETF. Supplement to the Prospectus

HSBC MSCI EMERGING MARKETS UCITS ETF Supplement. 23 May 2014

SPDR MSCI USA Small Cap Value Weighted UCITS ETF

SPDR MSCI Emerging Markets Small Cap UCITS ETF

SPDR MSCI ACWI IMI UCITS ETF

BetaBuilders US Treasury Bond 1-3 yr UCITS ETF

SPDR MSCI EM Asia UCITS ETF

USD Emerging Markets Sovereign Bond UCITS ETF

SPDR MSCI World Small Cap UCITS ETF

SPDR MSCI Emerging Markets UCITS ETF

HSBC MSCI EMERGING MARKETS UCITS ETF Supplement. 17 February 2017

USD Emerging Markets Sovereign Bond UCITS ETF

INVESCO MSCI EMERGING MARKETS UCITS ETF. Supplement to the Prospectus

SPDR MSCI USA Value UCITS ETF

SPDR MSCI EMU UCITS ETF

HSBC MSCI TURKEY UCITS ETF Supplement. 6 October 2014

HSBC MSCI CHINA UCITS ETF Supplement. 17 February 2017

SPDR S&P Emerging Markets Dividend UCITS ETF

BetaBuilders EUR Govt Bond 1-3 yr UCITS ETF

HSBC S&P BRIC 40 ETF Supplement 23 December 2010

SPDR S&P U.S. Consumer Staples Select Sector UCITS ETF

SPDR S&P U.S. Communication Services Select Sector UCITS ETF

HSBC MSCI KOREA UCITS ETF

SPDR S&P Pan Asia Dividend Aristocrats UCITS ETF

SPDR MSCI Europe Small Cap UCITS ETF

Xtrackers MSCI North America High Dividend Yield UCITS ETF. Supplement to the Prospectus

SPDR MSCI Europe Energy UCITS ETF

Global Research Enhanced Index Equity (ESG) UCITS ETF

HSBC MSCI CANADA UCITS ETF Supplement. 17 February 2017

SPDR BofA Merrill Lynch Emerging Markets Corporate Bond UCITS ETF

SPDR MSCI World Energy UCITS ETF

SPDR S&P U.S. Industrials Select Sector UCITS ETF

SPDR S&P 500 UCITS ETF

SPDR MSCI World Technology UCITS ETF

HSBC MSCI CANADA UCITS ETF

HSBC S&P BRIC 40 UCITS ETF Supplement. 16 March 2016

SPDR MSCI Europe Financials UCITS ETF

SPDR MSCI Europe Communication Services UCITS ETF

SPDR MSCI World Consumer Discretionary UCITS ETF

HSBC MSCI EUROPE UCITS ETF Supplement. 17 February 2017

SPDR MSCI Europe Consumer Discretionary UCITS ETF

SPDR BofA Merrill Lynch Emerging Markets Corporate Bond UCITS ETF

SPDR MSCI Europe Consumer Discretionary UCITS ETF

HSBC S&P 500 UCITS ETF

HSBC S&P 500 ETF Supplement 23 April 2010

Xtrackers MSCI World High Dividend Yield UCITS ETF. Supplement to the Prospectus

SPDR S&P U.S. Dividend Aristocrats UCITS ETF

SPDR ICE BofAML 0-5 Year EM USD Government Bond UCITS ETF

QNB Global Funds ICAV. QNB MENA Equities Fund. 26 January 2017 Supplement

HSBC S&P 500 UCITS ETF

SPDR EURO STOXX Low Volatility UCITS ETF

SPDR EURO STOXX Low Volatility UCITS ETF

SPDR Dow Jones Global Real Estate UCITS ETF

SPDR Thomson Reuters Global Convertible Bond UCITS ETF

SPDR S&P 500 UCITS ETF

NEUBERGER BERMAN INVESTMENT FUNDS PLC

INVESCO MSCI EUROPE VALUE UCITS ETF. Supplement to the Prospectus

Xtrackers MSCI AC World UCITS ETF. Supplement to the Prospectus

THE NT EMERGING MARKETS INDEX FUND

SPDR Morningstar Multi- Asset Global Infrastructure UCITS ETF

HSBC MSCI EM FAR EAST ETF

THE NT EMERGING MARKETS INDEX FUND SUPPLEMENT DATED 18 DECEMBER 2017 TO THE PROSPECTUS DATED 23 JUNE 2017 FOR NORTHERN TRUST INVESTMENT FUNDS PLC

INVESCO MSCI JAPAN UCITS ETF. Supplement to the Prospectus

INVESCO CONSUMER STAPLES S&P US SELECT SECTOR UCITS ETF. Supplement to the Prospectus

SPDR FTSE UK All Share UCITS ETF

JPMORGAN ETFS (IRELAND) ICAV MANAGED FUTURES UCITS ETF. 10 July 2018

CS ETF (IE) on iboxx EUR Govt 1-3

INVESCO EURO STOXX 50 UCITS ETF. Supplement to the Prospectus

SATRIX EMERGING MARKETS EQUITY TRACKER FUND. Supplement to the Prospectus dated 27 February 2018 for Sanlam Universal Funds plc

FINEX MSCI CHINA UCITS ETF. Supplement to the Prospectus

INVESCO MSCI SAUDI ARABIA UCITS ETF. Supplement to the Prospectus

LOOKING TO EXPAND YOUR INVESTMENT HORIZON? THE MODERN INDEX STRATEGY. msci.com

INVESCO RUSSELL 2000 UCITS ETF. Supplement to the Prospectus

FIFTH SUPPLEMENT. Dated 19 January to the Prospectus for Thornburg Global Investment plc

SPDR FTSE EPRA Europe ex UK Real Estate UCITS ETF

SPDR FTSE UK All Share UCITS ETF

INVESCO STOXX EUROPE SMALL 200 UCITS ETF. Supplement to the Prospectus

LAM Alternatif ZyFin Turkey Sovereign Bond UCITS ETF

HSBC FTSE EPRA/NAREIT DEVELOPED UCITS ETF Supplement. 17 February 2017

HSBC EURO STOXX 50 UCITS ETF Supplement. 17 February 2017

HSBC EURO STOXX 50 UCITS ETF Supplement. 6 October 2014

HSBC WORLDWIDE EQUITY UCITS ETF

INVESCO MORNINGSTAR US ENERGY INFRASTRUCTURE MLP UCITS ETF. Supplement to the Prospectus

IT ONLY TAKES ONE INDEX TO CAPTURE THE WORLD THE MODERN INDEX STRATEGY. msci.com

PRODUCT KEY FACTS BNY MELLON EMERGING MARKETS DEBT LOCAL CURRENCY FUND 30 April 2018

STATE STREET IRELAND UNIT TRUST

SATRIX WORLD EQUITY TRACKER FUND. Supplement to the Prospectus dated 27 February 2018 for Sanlam Universal Funds plc

INVESCO FTSE 250 UCITS ETF. Supplement to the Prospectus

SOURCE RBIS EQUAL RISK EQUITY US UCITS ETF. Supplement to the Prospectus

Segall Bryant & Hamill Emerging Markets Fund (Class A: SBHEX) (Class I: SBEMX)

WISDOMTREE US QUALITY DIVIDEND GROWTH UCITS ETF

INVESCO STOXX JAPAN EXPORTERS UCITS ETF. Supplement to the Prospectus

CS ETF (IE) on MSCI India

Causeway Funds plc. (the Company )

HSBC ESI WORLDWIDE EQUITY UCITS ETF

Transcription:

BMO UCITS ETF ICAV BMO MSCI Emerging Markets Income Leaders UCITS ETF 11 June 2018 (A sub-fund of BMO UCITS ETF ICAV, an Irish collective asset-management vehicle constituted as an umbrella fund with segregated liability between sub-funds with registered number C139810 authorised by the Central Bank of Ireland pursuant to the UCITS Regulations). This Supplement (the Supplement ) forms part of the Prospectus dated 11 June 2018 (the Prospectus ) in relation to BMO UCITS ETF ICAV (the Fund ) for the purposes of the UCITS Regulations. This Supplement should be read in the context of, and together with, the Prospectus and contains information relating to the BMO MSCI Emerging Markets Income Leaders UCITS ETF (the Sub-Fund ) which is a separate sub-fund of the Fund, represented by the BMO MSCI Emerging Markets Income Leaders UCITS ETF series of shares in the Fund (the Shares ). The Sub-Fund is an Index Tracking Sub-Fund and all Shares in this Sub-Fund are designated as ETF Shares. Prospective investors should review this Supplement and the Prospectus carefully and in their entirety and consider the risk factors set out in the Prospectus and in this Supplement before investing in this Sub-Fund. If you are in any doubt about the contents of this Supplement, you should consult your stockbroker, bank manager, solicitor, accountant and/or financial adviser. The Directors, as listed in the Management section of the Prospectus accept responsibility for the information contained in this Supplement. To the best of the knowledge and belief of the Directors (who have taken all reasonable care to ensure that such is the case) the information contained in this Supplement is in accordance with the facts and does not omit anything likely to affect the import of such information. The Directors accept responsibility accordingly. 34145598.31 1

Unless otherwise defined herein or unless the context otherwise requires, all defined terms used in this Supplement shall bear the same meaning as in the Prospectus. Base Currency US Dollar Dealing Deadline For cash subscriptions and redemptions, 16:30 (UK time) on the Business Day prior to each Dealing Day Dealing NAV Index Index Provider ISIN Minimum Subscription Amount Minimum Redemption Amount The Net Asset Value per Share calculated as at the Valuation Point on the relevant Dealing Day MSCI Emerging Markets Select Quality Yield Index MSCI IE00BZ053T90 100,000 Shares or cash equivalent 100,000 Shares or cash equivalent Settlement Deadline For cash subscriptions, appropriate cleared subscription monies must be received by the third (3) Business Day after the Dealing Day, or such later date as may be determined by the Fund and notified to Shareholders from time to time Valuation Valuation Point Website for the ETFs The Net Asset Value per Share is calculated in accordance with the Determination of Net Asset Value section of the Prospectus, using last traded prices for securities 22:15 (UK time) on each Business Day www.bmo.com/gam/uk/etf/etf-products# The Key investor information document for the sub funds will be available at: http://www.bmogam.com/kiids/ 2

INVESTMENT OBJECTIVE AND STRATEGY Investment Objective. The objective of the Sub-Fund is to provide an exposure to high quality large and mid-capitalisation emerging market stocks which have a history of paying above average dividends. Investment Policy. The investment policy of the Sub-Fund is to track the performance of the Index (or such other index determined by the Directors from time to time as being able to track substantially the same market as the Index and which is considered by the Directors to be an appropriate index for the Sub-Fund to track, in accordance with the Prospectus) as closely as possible, regardless of whether the Index level rises or falls, while seeking to minimise as far as possible the tracking error between the Sub-Fund s performance and that of the Index. Any determination by the Directors that the Sub-Fund should track another index at any time shall be subject to the provision of reasonable notice to Shareholders to enable any Shareholders who wish to do so to redeem their Shares prior to implementation of this change and the Supplement will be updated accordingly. The Index consists of large and mid-capitalisation stocks issued by issuers in emerging markets which exhibit comparatively high quality growth characteristics and dividend yields compared to the component securities of the MSCI Emerging Markets Index, the Index s parent index. As of the date of this Supplement, the index comprises issuers from Brazil, Chile, China, Colombia, the Czech Republic, Egypt, Greece, Hong Kong, Hungary, India, Indonesia, Korea, Malaysia, Mexico, Peru, Philippines, Poland, Russia, Qatar, South Africa, Taiwan, Thailand, Turkey and the United Arab Emirates. Investment in Russia will only take place on the Moscow Stock Exchange. Index Securities are selected through a two step screening process. The first step is to identify the 50% of constituents of the MSCI Emerging Markets Index, which score highest on three main fundamental variables: high return on equity (ROE), stable year-over-year earnings growth and low financial leverage. The second step is to identify the 50% of the securities identified through the first step which have the highest dividend yield. The Index rebalances on a semi-annual basis (as referred to in the Index Tracking Risk section of the prospectus) and is market capitalisation weighted with a 5% issuer cap. Further details on the Index, including its components and performance, are available at http://www.msci.com. In order to seek to achieve this investment objective, the Investment Manager will aim to replicate the Index by holding all of the Index Securities in a similar proportion to their weighting in the Index. However, where full replication of the Index is not reasonably possible (for example as a result of the number of securities or the illiquidity of certain securities within the Index), the Sub-Fund will use the optimisation methodology to select Index Securities in order to build a representative portfolio that provides a return that is comparable to that of the Index. Consequently, the Sub-Fund may over certain periods only hold a certain sub-set of the Index Securities. Further information on the use of sampling methodology can be found under Index Tracking Sub-Funds in the Investment Objectives and Policies section of the Prospectus. The Sub-Fund may hold some securities which are not constituents of the Index, where such securities provide similar exposure (with similar risk profiles) to certain securities that make up the Index. These securities, which are not constituents of the Index, are selected by virtue of the fact that they provide substantively the same exposure by industry, and by company characteristics in the case of liquidity considerations or corporate actions to certain Index Securities. The securities in which the Sub-Fund invests will be primarily listed or traded on Recognised Markets globally in accordance with the limits set out in the UCITS Regulations. The Sub-Fund may hold ancillary liquid assets (deposits, commercial paper and short term commercial paper) in accordance with the UCITS Regulations. The Sub-Fund may also invest in other regulated, open-ended collective investment schemes as described under General Investment Techniques in the Investment Objectives and Policies where the objectives of such funds are consistent with the objective of the Sub-Fund. The Sub-Fund will use the replication and optimisation strategies and may also invest in other regulated open-ended funds as described above in order to seek to track as closely as possible the returns of the Index after deduction of Fees and Expenses. For information in relation to the 3

difficulties associated with tracking indices, please refer to Index Tracking Risk in the Risk Information section of the Prospectus. It is currently anticipated that the tracking error of the Sub- Fund will be up to 60 bps under normal market conditions where the tracking error is defined as the standard deviation of the delivered excess returns over an annual period. The causes of tracking error for ETFs can include, but are not limited to the following: holdings/size of the Sub-Fund, cash flows, such as any delays in investing subscription proceeds into the Sub-Fund or realising investments to meet redemptions, fees and the frequency of rebalancing against the Index. For further information in relation to the difficulties associated with tracking indices, please refer to Index Tracking Risk in the Risk Information section of the Prospectus. Optimisation strategies seek to minimise tracking error through proprietary quantitative portfolio analysis. This analysis may include consideration of matters such as how a securities price changes in relation to another over time, scenario analysis (which involves estimating the change in an investment portfolio s value given a change in key risk factors) and stress testing. The optimisation process analyses portfolio holdings, benchmark weights and risk model data and then computes an optimal portfolio. Transaction costs to implement the target portfolio are also analysed before constructing the Sub-Fund s portfolio. The use of optimisation may not always result in tracking error being miminised as intended. INVESTMENT RISKS Investment in the Sub-Fund carries with it a degree of risk including the risks described in the Risk Information section of the Prospectus. These risks are not intended to be exhaustive and potential investors should review the Prospectus and this Supplement carefully and consult with their professional advisers before purchasing Shares. As the Sub-Fund has material exposure to emerging markets, an investment in the Sub-Fund should not constitute a substantial portion of an investment portfolio and may not be appropriate for all investors. In addition, there is no limit to the exposure that the Sub-Fund may take to Russia and it is expected to match that of the Index (as at November 2016, exposure to Russia amounted to approximately 3% of the Index). Please refer to the Russian Investment Risk in the Risk Information section of the Prospectus. Emerging Markets Risk. Investments in securities of companies from multiple countries and/or securities of companies with significant exposure to multiple countries can involve additional risks. Political, social and economic instability, the imposition of currency or capital controls or the expropriation or nationalisation of assets in a particular country can cause dramatic declines in that country s economy. Less stringent regulatory, accounting and disclosure requirements for issuers and markets are common in certain countries. Enforcing legal rights can be difficult, costly and slow in some countries and can be particularly difficult against governments. Additional risks of investing in various countries include trading, settlement, custodial and other operational risks due to different systems, procedures and requirements in a particular country and varying laws regarding withholding and other taxes. These factors can make investments in multiple countries, especially investments in emerging or less developed markets, more volatile and less liquid than investments in a single country and could potentially result in an adverse effect on the Sub-Fund s performance. Further, investment in emerging markets subjects the Sub-Fund to a greater risk of loss than investments in developed markets. This is due to, among other things: greater market volatility; lower trading volume and liquidity issues; limited securities markets; restrictions on purchases of securities by foreign investors; political and economic instability; economic dependence on a few industries or on international trade or revenue from particular commodities; 4

high levels of inflation, deflation or currency devaluation; regulatory, financial reporting, accounting and disclosure standards that may be less stringent than those of developed markets; settlement and custodial systems that are not as well-developed as those in developed markets that may cause delays in settlement and possible failed settlements ; precarious financial stability of issuers (including governments); greater risk of market shut down; and more governmental limitations on foreign investment policy than those typically found in a developed market. The foregoing factors may cause the Sub-Fund s investments to be more volatile than if the Sub-Fund invested in more developed markets and may cause the Sub-Fund to realise losses. This risk of increased volatility and losses may be magnified by currency fluctuations relative to the Base Currency. INVESTOR PROFILE Typical investors in the Sub-Fund are expected to be retail and institutional investors who want to take a long or short-term exposure to the market covered by the Index and are prepared to accept the risks associated with an investment of this type, including the volatility of such market. SUBSCRIPTIONS PRIMARY MARKET Shares will be issued on each Dealing Day at the Dealing NAV with an appropriate provision for Duties and Charges in accordance with the provisions set out below and in the Prospectus. Authorised Participants may subscribe for Shares for cash or in kind on each Dealing Day by making an application by the Dealing Deadline in accordance with the requirements set out below and in the Purchase and Sale Information section of the Prospectus. Consideration, in the form of cleared subscription monies/securities, must be received by the applicable Settlement Deadline. REDEMPTIONS Shareholders may effect a redemption of Shares on any Dealing Day at the appropriate Dealing NAV, subject to an appropriate provision for Duties and Charges, provided that a written redemption request is signed by the Shareholder and received by the Administrator by the Dealing Deadline on the relevant Dealing Day, in accordance with the provisions set out in this section and at the Purchase and Sale Information section of the Prospectus. Settlement will normally take place within three Business Days of the Dealing Day but may take longer depending on the settlement schedule of the underlying markets. In any event, settlement will not take place later than 10 Business Days from the Dealing Deadline. FEES AND EXPENSES The TER for the Sub-Fund will be up to 0.38% per annum of the Net Asset Value. Further information in this respect is set out in the Fees and Expenses section of the Prospectus. CONVERSIONS Shares in the Sub-Fund may not be exchanged for shares in another Sub-Fund. LISTING 5

Shares were admitted to the Official List and to trading on the Main Securities Market of the Irish Stock Exchange plc, trading as Euronext Dublin on 1 December 2016. INDEX DISCLAIMERS THIS SUB-FUND IS NOT SPONSORED, ENDORSED, SOLD OR PROMOTED BY MSCI INC. ( MSCI ), ANY OF ITS AFFILIATES, ANY OF ITS INFORMATION PROVIDERS OR ANY OTHER THIRD PARTY INVOLVED IN, OR RELATED TO, COMPILING, COMPUTING OR CREATING ANY MSCI INDEX (COLLECTIVELY, THE MSCI PARTIES ). THE MSCI INDEXES ARE THE EXCLUSIVE PROPERTY OF MSCI. MSCI AND THE MSCI INDEX NAMES ARE SERVICE MARK(S) OF MSCI OR ITS AFFILIATES AND HAVE BEEN LICENSED FOR USE FOR CERTAIN PURPOSES BY THE INVESTMENT MANAGER. NONE OF THE MSCI PARTIES MAKES ANY REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, TO THE FUND OR OWNERS OF THE SHARES OR ANY OTHER PERSON OR ENTITY REGARDING THE ADVISABILITY OF INVESTING IN FUNDS GENERALLY OR IN THIS SUB-FUND PARTICULARLY OR THE ABILITY OF ANY MSCI INDEX TO TRACK CORRESPONDING STOCK MARKET PERFORMANCE. MSCI OR ITS AFFILIATES ARE THE LICENSORS OF CERTAIN TRADEMARKS, SERVICE MARKS AND TRADE NAMES AND OF THE MSCI INDEXES WHICH ARE DETERMINED, COMPOSED AND CALCULATED BY MSCI WITHOUT REGARD TO THIS SUB-FUND OR THE FUND OR OWNERS OF SHARES OR ANY OTHER PERSON OR ENTITY. NONE OF THE MSCI PARTIES HAS ANY OBLIGATION TO TAKE THE NEEDS OF THE FUND OR OWNERS OF THE SHARES OR ANY OTHER PERSON OR ENTITY INTO CONSIDERATION IN DETERMINING, COMPOSING OR CALCULATING THE MSCI INDEXES. NONE OF THE MSCI PARTIES IS RESPONSIBLE FOR OR HAS PARTICIPATED IN THE DETERMINATION OF THE TIMING OF, PRICES AT, OR QUANTITIES OF THIS SUB-FUND TO BE ISSUED OR IN THE DETERMINATION OR CALCULATION OF THE EQUATION BY OR THE CONSIDERATION INTO WHICH THIS SUB-FUND IS REDEEMABLE. FURTHER, NONE OF THE MSCI PARTIES HAS ANY OBLIGATION OR LIABILITY TO THE FUND OR OWNERS OF THE SHARES OR ANY OTHER PERSON OR ENTITY IN CONNECTION WITH THE ADMINISTRATION, MARKETING OR OFFERING OF THIS SUB- FUND. ALTHOUGH MSCI SHALL OBTAIN INFORMATION FOR INCLUSION IN OR FOR USE IN THE CALCULATION OF THE MSCI INDEXES FROM SOURCES THAT MSCI CONSIDERS RELIABLE, NONE OF THE MSCI PARTIES WARRANTS OR GUARANTEES THE ORIGINALITY, ACCURACY AND/OR THE COMPLETENESS OF ANY MSCI INDEX OR ANY DATA INCLUDED THEREIN. NONE OF THE MSCI PARTIES MAKES ANY WARRANTY, EXPRESS OR IMPLIED, AS TO RESULTS TO BE OBTAINED BY THE FUND, THE SUB-FUND, OWNERS OF THE SHARES, OR ANY OTHER PERSON OR ENTITY, FROM THE USE OF ANY MSCI INDEX OR ANY DATA INCLUDED THEREIN. NONE OF THE MSCI PARTIES SHALL HAVE ANY LIABILITY FOR ANY ERRORS, OMISSIONS OR INTERRUPTIONS OF OR IN CONNECTION WITH ANY MSCI INDEX OR ANY DATA INCLUDED THEREIN. FURTHER, NONE OF THE MSCI PARTIES MAKES ANY EXPRESS OR IMPLIED WARRANTIES OF ANY KIND, AND THE MSCI PARTIES HEREBY EXPRESSLY DISCLAIM ALL WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO EACH MSCI INDEX AND ANY DATA INCLUDED THEREIN. WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT SHALL ANY OF THE MSCI PARTIES HAVE ANY LIABILITY FOR ANY DIRECT, INDIRECT, SPECIAL, PUNITIVE, CONSEQUENTIAL OR ANY OTHER DAMAGES (INCLUDING LOST PROFITS) EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES. 6